Citations (11)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
George J Wan, John Niewoehner & Kyle Hayes. (2023) Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence. ClinicoEconomics and Outcomes Research 15, pages 499-512.
Read now
Read now
H. Reginald McDaniel, Christopher LaGanke, Laura Bloom, Sharon Goldberg, Lucas C. Lages, Laura A. Lantigua, Steven E. Atlas, Judi M. Woolger & John E. Lewis. (2020) The Effect of a Polysaccharide-Based Multinutrient Dietary Supplementation Regimen on Infections and Immune Functioning in Multiple Sclerosis. Journal of Dietary Supplements 17:2, pages 184-199.
Read now
Read now
Itay Raphael, Johanna Webb, Olaf Stuve, William Haskins & Thomas Forsthuber. (2015) Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future. Expert Review of Clinical Immunology 11:1, pages 69-91.
Read now
Read now
Articles from other publishers (8)
Sergey M. Karpov, Irina A. Vyshlova, Anna I. Klimenko, Evgenii A. Tkachenko, Rustam N. Gadaborshev & Akhshar I. Dzutsev. (2023) Multiple sclerosis in the context of the COVID-19 pandemic. Neurology Bulletin LV:1, pages 47-53.
Crossref
Crossref
Eman M. Khedr, Islam El Malky, Hussein B. Hussein, Doaa M. Mahmoud & Ayman Gamea. (2023) Multiple sclerosis diagnostic delay and its associated factors in Upper Egyptian patients. Scientific Reports 13:1.
Crossref
Crossref
J. Bradford Rice, Mary P. Panaccio, Alan White, Mark Simes, Emma Billmyer, Nathaniel Downes, John Niewoehner & George J. Wan. (2020) Consequences of Insurance Denials Among U.S. Patients Prescribed Repository Corticotropin Injection for Acute Exacerbations of Multiple Sclerosis. Neurology and Therapy 10:1, pages 149-167.
Crossref
Crossref
Juliana Helena dos Santos de Toledo, Thais Fernanda de Campos Fraga-Silva, Patrícia Aparecida Borim, Larissa Ragozo Cardoso de Oliveira, Evelyn da Silva Oliveira, Larissa Lucena Périco, Clélia Akiko Hiruma-Lima, Adriana Aparecida Lopes de Souza, Carlos Alberto Ferreira de Oliveira, Pedro de Magalhães Padilha, Marcos Felipe Pinatto-Botelho, Alcindo Aparecido dos Santos, Alexandrina Sartori & Sofia Fernanda Gonçalves Zorzella-Pezavento. (2020) Organic Selenium Reaches the Central Nervous System and Downmodulates Local Inflammation: A Complementary Therapy for Multiple Sclerosis?. Frontiers in Immunology 11.
Crossref
Crossref
Danielle Bernardes & Alexandre Leite Rodrigues de Oliveira. (2018) Regular Exercise Modifies Histopathological Outcomes of Pharmacological Treatment in Experimental Autoimmune Encephalomyelitis. Frontiers in Neurology 9.
Crossref
Crossref
Gabriel Pardo & David E. Jones. (2017) The sequence of disease-modifying therapies in relapsing multiple sclerosis: safety and immunologic considerations. Journal of Neurology 264:12, pages 2351-2374.
Crossref
Crossref
Samiie Pouragahi, Marjan Nassiri-Asl, Mohammad Ali Sahraian, Mehdi Sadeghi, Abdolali Banki, Zahra Zamanzadeh, Mitra Ataei & Mohammad Hossein Sanati. (2016) Utility of Myelin Basic Protein as an Early Prognostic Biomarker in Multiple Sclerosis. Iranian Red Crescent Medical Journal 19:3.
Crossref
Crossref
Kyriakos Souliotis, Elena Alexopoulou, Manto Papageorgiou, Anastasia Politi, Panagiota Litsa & Xenophon Contiades. (2015) Access to Care for Multiple Sclerosis in Times of Economic Crisis in Greece – the HOPE II Study. International Journal of Health Policy and Management 5:2, pages 83-89.
Crossref
Crossref